Primary Tumor Resection Decelerates Disease Progression in an Orthotopic Mouse Model of Metastatic Prostate Cancer
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
In: 10.3390/cancers14030737
- Event
-
Veröffentlichung
- (where)
-
Aachen
- (who)
-
Universitätsbibliothek der RWTH Aachen
- (when)
-
2022
- Creator
-
Linxweiler, Johannes
Hajili, Turkan
Zeuschner, Philip
Menger, Michael D.
Stöckle, Michael
Junker, Kerstin
Saar, Matthias
- DOI
-
10.18154/RWTH-CONV-250239
- URN
-
urn:nbn:de:101:1-2023012900395726410027
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
25.03.2025, 1:41 PM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Linxweiler, Johannes
- Hajili, Turkan
- Zeuschner, Philip
- Menger, Michael D.
- Stöckle, Michael
- Junker, Kerstin
- Saar, Matthias
- Universitätsbibliothek der RWTH Aachen
Time of origin
- 2022
Other Objects (12)
CCR5 status and metastatic progression in colorectal cancer
⁶⁸Ga-PSMA PET for the assessment of metastatic prostate cancer
Angio-regulation of liver neovascularization and lung metastatic progression
Metabolic changes during prostate cancer development and progression
Effect of chemotherapy in metastatic prostate cancer according to race/ethnicity groups
Effect of chemotherapy on overall survival in contemporary metastatic prostate cancer patients
Diabetes and beta adrenergic blockage are risk factors for metastatic prostate cancer
Clinical Actionability of the Genomic Landscape of Metastatic Castration Resistant Prostate Cancer
Regulation of S100A8 and S100A9 expression in prostate cancer and impact for prostate cancer progression
Liposomal delivery of dexamethasone attenuates prostate cancer bone metastatic tumor growth In Vivo
Safety and survival of docetaxel and cabazitaxel in metastatic castration-resistant prostate cancer
Mechanistic analysis and preclinical validation of novel combination therapies targeting metastatic progression
CCR5 status and metastatic progression in colorectal cancer
⁶⁸Ga-PSMA PET for the assessment of metastatic prostate cancer
Angio-regulation of liver neovascularization and lung metastatic progression
Metabolic changes during prostate cancer development and progression
Effect of chemotherapy in metastatic prostate cancer according to race/ethnicity groups
Effect of chemotherapy on overall survival in contemporary metastatic prostate cancer patients
Diabetes and beta adrenergic blockage are risk factors for metastatic prostate cancer
Clinical Actionability of the Genomic Landscape of Metastatic Castration Resistant Prostate Cancer
Regulation of S100A8 and S100A9 expression in prostate cancer and impact for prostate cancer progression
Liposomal delivery of dexamethasone attenuates prostate cancer bone metastatic tumor growth In Vivo
Safety and survival of docetaxel and cabazitaxel in metastatic castration-resistant prostate cancer
Mechanistic analysis and preclinical validation of novel combination therapies targeting metastatic progression
CCR5 status and metastatic progression in colorectal cancer
⁶⁸Ga-PSMA PET for the assessment of metastatic prostate cancer
Angio-regulation of liver neovascularization and lung metastatic progression
Metabolic changes during prostate cancer development and progression
Effect of chemotherapy in metastatic prostate cancer according to race/ethnicity groups
Effect of chemotherapy on overall survival in contemporary metastatic prostate cancer patients
Diabetes and beta adrenergic blockage are risk factors for metastatic prostate cancer
Clinical Actionability of the Genomic Landscape of Metastatic Castration Resistant Prostate Cancer
Regulation of S100A8 and S100A9 expression in prostate cancer and impact for prostate cancer progression
Liposomal delivery of dexamethasone attenuates prostate cancer bone metastatic tumor growth In Vivo
Safety and survival of docetaxel and cabazitaxel in metastatic castration-resistant prostate cancer